Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04924075 |
|---|---|
| Brief Title: | Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) |
| First Submitted : | June 8, 2021 |
| First Submitted that Met QC Criteria : | June 8, 2021 |
| First Posted : | June 11, 2021 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 7, 2024 |